Duration of Hormonal Contraception and Risk of Cervical Cancer

  • Auckland University of Technology ROR
  • Ministry Of Health ROR
  • Ministry of Health of the Russian Federation ROR

Kesmas: National Public Health Journal, 14(1)

DOI 10.21109/kesmas.v14i1.2713 Source

Abstract

The use of long hormonal contraceptives can disrupt the balance of estrogen in the body, resulting in abnormal cell changes. This study aimed to determine a correlation between the duration of hormonal contraception and risk of cervical cancer. This study used a case-control design. The population were patients who had examined at a cancer installation and obstetrics-gynecology polyclinic Dr. Sardjito Hospital in 2018. Case samples were 95 women have cervical cancer diagnosis and control were 95 women with a negative pap smear. Sampling with random sampling. Dependent variable cervical cancer and independent variable the duration of hormonal contraception are obtained from medical records. Cervical cancer is assessed by doctor’s diagnosis. Data analysis used logistic regression. Results showed that 44.7% of samples used long-term hormonal contraception (over 5 years). Length of use of hormonal contraception had a significant correlation with the incidence of cervical cancer (p-value < 0.01). Hormonal contraceptive use more than 5 years have a risk 4.2 times (95% CI 1.01-5.69) of cervical cancer than using less than 5 years after being controlled with the first marriage age and parity

Topics

hormonal contraception duration cervical cancer risk, long-term hormonal contraceptive use cervical cancer case-control, estrogen imbalance hormonal contraceptives abnormal cell changes cervix, oral contraceptive pill cervical cancer risk factor, hormonal contraception more than five years cancer risk, contraceptive duration cervical cancer parity marriage age, case-control study hormonal contraception cervical cancer hospital, pap smear cervical cancer hormonal contraceptive users, estrogen disruption contraceptive side effects cervical pathology, logistic regression hormonal contraception cervical cancer risk
DOI 10.21109/kesmas.v14i1.2713 10.21109/kesmas.v14i1.2713

Cite this article

Kusmiyati, Y., Prasistyami, A., Wahyuningsih, H. P., Widyasih, H., & Adnani, Q. E. S. (2019). Duration of Hormonal Contraception and Risk of Cervical Cancer. *Kesmas: National Public Health Journal*, *14*(1). https://doi.org/10.21109/kesmas.v14i1.2713

Related articles